Rimiducid-activated GoCAR-T® resulted in significant expansion and persistence of T cells Initial evidence of biologic activity and stable disease observed in…
GAITHERSBURG, Md., Dec. 11, 2018 (GLOBE NEWSWIRE) — NexImmune, an emerging leader in the field of antigen-directed immunotherapy, today announced…
CHICAGO–(BUSINESS WIRE)–The modern warfighter is about to get a big upgrade with some tiny but powerful technology. The U.S. Army…
SAN DIEGO, Dec. 03, 2018 (GLOBE NEWSWIRE) — Poseida Therapeutics Inc., a clinical-stage biopharmaceutical company leveraging proprietary non-viral gene engineering…
Results show high rates of Relapse Free Survival and Overall Survival in pediatric patients with acute leukemias with median follow-up…
Interim results suggest rivo-cel outcomes were comparable to a control study of transplants from matched unrelated donors, a requirement for…
Experience to date in clinical study shows high clinical response rates for patients with visceral GvHD or GvHD that was…